Effects of Pilate Training Versus Moderate Intensity Continous Training in Hypertensive Patients

Not Applicable

Active, not recruiting

• Conditions: Prehypertension

• Registration Number: NCT06762262
• Lead Sponsor: Riphah International University

Brief Summary

Hypertension, commonly known as high blood pressure, continues to be the leading cause of both sickness and mortality globally. Generally, individuals in good health might have trouble breathing solely during vigorous exercise or when holding their breath, finding relief by stopping the activity or adjusting their breathing technique. Often patients with hypertension seek various treatments to relieve symptoms. The aim of this study is to compare the effects of Pilates Training and Moderate Intensity Continuous Training on dyspnea and cardiovascular fitness in hypertensive patients. The study would be randomized clinical trial. A total of thirty-four subjects will be assigned randomly by using block randomization into two groups. Group A will be given Pilates training while Group B will moderate intensity training. After confirmation of diagnosis with medical history and physical examination as well as chronic, mild-to moderate, and stable (\>1 year duration) hypertension (systolic blood pressure \[SBP\] between 140-179 mm Hg and diastolic blood pressure \[DBP\]between 90-109 mm Hg) recommended. 3-minute step test, VO2max and Modified BORG scale would be used as an outcome measure tools for cardiovascular parameters and dyspnea. The collected data will be analyzed in SPSS 25.0. Descriptive and inferential statistics will be applied after testing normality of data

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2024-04-20
• Primary Completion: 2024-12-30
• Status Verified: 2025-01
• Study First Submitted: 2025-01-01
• Study First Submitted QC: 2025-01-01
• Last Update Submitted: 2025-01-01
• Study First Posted: 2025-01-07
• Last Update Posted: 2025-01-07
• Study Completion: 2025-04-30

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 52

Inclusion Criteria

• Participants must be between 45 to 70 years old
• Gender: Male and Female both
• Chronic, mild-to moderate, and stable (>1 year duration) hypertension (systolic blood pressure
• [SBP] between 140-179 mm Hg and diastolic blood pressure [DBP] between 90-109 mm Hg).
• Single antihypertensive medication will be recruited.
• Participants have sedentary life style.
• Smokers, alcoholic, diabetic, and other cardiac problems (controlled) would be included.

Read More

Exclusion Criteria

• Patients with Permanent atrial fibrillation
• Patients with COPD
• Patients with Heart surgery
• Patients with presence of symptomatic congestive heart failure
• Smokers, alcoholic, diabetic, and other cardiac, renal, and respiratory disease patients (uncontrolled) would be excluded.
• Participants with no history of psychiatry or psychological disorders or abnormalities.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
6 MWT	8 weeks
VO2 max	8 weeks
Borg Dyspnea Scale	8 weeks

Trial Locations

Locations (1)

Sheikh Zaid Hospital; 🇵🇰 Quetta, Balochistan, Pakistan